H.R. 2815 · 117th Congress
BIOSIM Act
- Stage
- In committee
- Sponsor
- Kurt Schrader
- Introduced
- 2021-04-22
- Latest action
- 2021-04-23 · Referred to the Subcommittee on Health.
Summary
Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act
This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.